HOME › DRUGS › TIXAGEVIMAB;CILGAVIMAB
ACTIVE SUBSTANCE / INN

TIXAGEVIMAB;CILGAVIMAB

Brand name(s): Evusheld
EMA LISTED
WITHDRAWN
COVID-19 virus infection
ACTIVE SUBSTANCE
Tixagevimab;Cilgavimab
REGULATORS
EMA
SPONSORS / MAH
AstraZeneca AB
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
EvusheldAstraZeneca ABWithdrawn25/03/2022COVID-19 virus infection

FULL INTELLIGENCE ON TIXAGEVIMAB;CILGAVIMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →